Debbie Rigby rounds up the latest in research news Over-the-counter use of short-acting beta-2 agonists The availability of SABA as an over-the-counter (OTC) medication has contributed to overuse, leading to undertreated asthma and reduced access to asthma education. SABA overuse refers to the use of three or more SABA canisters in a year. Excessive use
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.